Cargando…
Taste-Masked Flucloxacillin Powder Part 1: Optimisation of Fabrication Process Using a Mixture Design Approach
It is extremely challenging to formulate age-appropriate flucloxacillin medicines for young children, because flucloxacillin sodium (FS) has a lingering, highly bitter taste, dissolves quickly in saliva, and requires multiple daily dosing at relatively large doses for treating skin infections. In th...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458362/ https://www.ncbi.nlm.nih.gov/pubmed/37631086 http://dx.doi.org/10.3390/ph16081171 |
_version_ | 1785097148648390656 |
---|---|
author | Yoo, Okhee Salman, Sam von Ungern-Sternberg, Britta S. Lim, Lee Yong |
author_facet | Yoo, Okhee Salman, Sam von Ungern-Sternberg, Britta S. Lim, Lee Yong |
author_sort | Yoo, Okhee |
collection | PubMed |
description | It is extremely challenging to formulate age-appropriate flucloxacillin medicines for young children, because flucloxacillin sodium (FS) has a lingering, highly bitter taste, dissolves quickly in saliva, and requires multiple daily dosing at relatively large doses for treating skin infections. In this paper, we describe a promising taste-masked flucloxacillin ternary microparticle (FTM) formulation comprising FS, Eudragit EPO (EE), and palmitic acid (PA). To preserve the stability of the thermolabile and readily hydrolysed flucloxacillin, the fabrication process employed a non-aqueous solvent evaporation method at ambient temperature. Optimisation of the fabrication method using a mixture design approach resulted in a robust technique that generated stable and reproducible FTM products. The optimised method utilised only a single solvent evaporation step and minimal amounts of ICH class III solvents. It involved mixing two solution phases—FS dissolved in ethanol:acetone (1:4 v/v), and a combination of EE and PA dissolved in 100% ethanol—to give a ternary FS:EE:PA system in ethanol: acetone (3:1 v/v). Solvent evaporation yielded the FTMs containing an equimolar ratio of FS:EE:PA (1:0.8:0.6 w/w). The fabrication process, after optimisation, demonstrated robustness, reproducibility, and potential scalability. |
format | Online Article Text |
id | pubmed-10458362 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-104583622023-08-27 Taste-Masked Flucloxacillin Powder Part 1: Optimisation of Fabrication Process Using a Mixture Design Approach Yoo, Okhee Salman, Sam von Ungern-Sternberg, Britta S. Lim, Lee Yong Pharmaceuticals (Basel) Article It is extremely challenging to formulate age-appropriate flucloxacillin medicines for young children, because flucloxacillin sodium (FS) has a lingering, highly bitter taste, dissolves quickly in saliva, and requires multiple daily dosing at relatively large doses for treating skin infections. In this paper, we describe a promising taste-masked flucloxacillin ternary microparticle (FTM) formulation comprising FS, Eudragit EPO (EE), and palmitic acid (PA). To preserve the stability of the thermolabile and readily hydrolysed flucloxacillin, the fabrication process employed a non-aqueous solvent evaporation method at ambient temperature. Optimisation of the fabrication method using a mixture design approach resulted in a robust technique that generated stable and reproducible FTM products. The optimised method utilised only a single solvent evaporation step and minimal amounts of ICH class III solvents. It involved mixing two solution phases—FS dissolved in ethanol:acetone (1:4 v/v), and a combination of EE and PA dissolved in 100% ethanol—to give a ternary FS:EE:PA system in ethanol: acetone (3:1 v/v). Solvent evaporation yielded the FTMs containing an equimolar ratio of FS:EE:PA (1:0.8:0.6 w/w). The fabrication process, after optimisation, demonstrated robustness, reproducibility, and potential scalability. MDPI 2023-08-17 /pmc/articles/PMC10458362/ /pubmed/37631086 http://dx.doi.org/10.3390/ph16081171 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Yoo, Okhee Salman, Sam von Ungern-Sternberg, Britta S. Lim, Lee Yong Taste-Masked Flucloxacillin Powder Part 1: Optimisation of Fabrication Process Using a Mixture Design Approach |
title | Taste-Masked Flucloxacillin Powder Part 1: Optimisation of Fabrication Process Using a Mixture Design Approach |
title_full | Taste-Masked Flucloxacillin Powder Part 1: Optimisation of Fabrication Process Using a Mixture Design Approach |
title_fullStr | Taste-Masked Flucloxacillin Powder Part 1: Optimisation of Fabrication Process Using a Mixture Design Approach |
title_full_unstemmed | Taste-Masked Flucloxacillin Powder Part 1: Optimisation of Fabrication Process Using a Mixture Design Approach |
title_short | Taste-Masked Flucloxacillin Powder Part 1: Optimisation of Fabrication Process Using a Mixture Design Approach |
title_sort | taste-masked flucloxacillin powder part 1: optimisation of fabrication process using a mixture design approach |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458362/ https://www.ncbi.nlm.nih.gov/pubmed/37631086 http://dx.doi.org/10.3390/ph16081171 |
work_keys_str_mv | AT yoookhee tastemaskedflucloxacillinpowderpart1optimisationoffabricationprocessusingamixturedesignapproach AT salmansam tastemaskedflucloxacillinpowderpart1optimisationoffabricationprocessusingamixturedesignapproach AT vonungernsternbergbrittas tastemaskedflucloxacillinpowderpart1optimisationoffabricationprocessusingamixturedesignapproach AT limleeyong tastemaskedflucloxacillinpowderpart1optimisationoffabricationprocessusingamixturedesignapproach |